Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2011, Article ID 732690, 6 pages
http://dx.doi.org/10.1155/2011/732690
Research Article

Identification of Differentially Expressed MicroRNAs in Osteosarcoma

1Division of Hematology, Oncology and Stem Cell Transplantation, Children's Memorial Hospital, 2300 Children's Plaza, Chicago, IL 60614, USA
2Department of Pediatrics, Feinberg School of Medicine Northwestern University, Chicago, IL 60611, USA
3Cancer Biology and Epigenomics Program, Children's Memorial Research Center, Chicago, IL 60614, USA
4Division of Anatomic Pathology, Children's Memorial Hospital, Chicago, IL 60614, USA

Received 1 April 2011; Accepted 10 June 2011

Academic Editor: Alessandro Gronchi

Copyright © 2011 Rishi R. Lulla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Kansara and D. M. Thomas, “Molecular pathogenesis of osteosarcoma,” DNA and Cell Biology, vol. 26, no. 1, pp. 1–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Hansen, “Genetic and molecular aspects of osteosarcoma,” Journal of Musculoskeletal Neuronal Interactions, vol. 2, no. 6, pp. 554–560, 2002. View at Google Scholar · View at Scopus
  3. A. Patiño-García, E. Sotillo Piñeiro, M. Zalacaín Díez, L. Gárate Iturriagagoitia, F. Antillón Klüssmann, and L. S. Ariznabarreta, “Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas,” Journal of Pediatric Hematology/Oncology, vol. 25, no. 5, pp. 362–367, 2003. View at Publisher · View at Google Scholar
  4. P. Hou, M. Ji, B. Yang et al., “Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma,” Cancer, vol. 106, no. 7, pp. 1602–1609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. F. F. Costa, “Non-coding RNAs, epigenetics and complexity,” Gene, vol. 410, no. 1, pp. 9–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Wurdinger and F. F. Costa, “Molecular therapy in the microRNA era,” Pharmacogenomics Journal, vol. 7, no. 5, pp. 297–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. K. Shenouda and S. K. Alahari, “MicroRNA function in cancer: oncogene or a tumor suppressor?” Cancer and Metastasis Reviews, vol. 28, no. 3-4, pp. 369–378, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Passetti, C. G. Ferreira, and F. F. Costa, “The impact of microRNAs and alternative splicing in pharmacogenomics,” Pharmacogenomics Journal, vol. 9, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Zhang, Y. Li, and M. Lai, “The microRNA network and tumor metastasis,” Oncogene, vol. 29, no. 7, pp. 937–948, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. He, J. Xiong, X. Xu et al., “Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples,” Biochemical and Biophysical Research Communications, vol. 388, no. 1, pp. 35–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Song, Y. Wang, Y. Xi et al., “Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells,” Oncogene, vol. 28, no. 46, pp. 4065–4074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Song, Y. Wang, M. A. Titmus et al., “Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells,” Molecular Cancer, vol. 9, article 96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Ziyan, Y. Shuhua, W. Xiufang, and L. Xiaoyun, “MicroRNA-21 is involved in osteosarcoma cell invasion and migration,” Medical Oncology. In press. View at Publisher · View at Google Scholar
  14. H. Zhang, X. Cai, Y. Wang, H. Tang, D. Tong, and F. Ji, “MicroRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2,” Oncology Reports, vol. 24, no. 5, pp. 1363–1369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Chen, D. A. Ridzon, A. J. Broomer et al., “Real-time quantification of microRNAs by stem-loop RT-PCR,” Nucleic Acids Research, vol. 33, no. 20, pp. e179.1–e179.9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. K. Raymond, B. S. Roberts, P. Garrett-Engele, L. P. Lim, and J. M. Johnson, “Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs,” RNA, vol. 11, no. 11, pp. 1737–1744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Doleshal, A. A. Magotra, B. Choudhury, B. D. Cannon, E. Labourier, and A. E. Szafranska, “Evaluation and validation of total RNA extraction methods for microRNA expression analyses in formalin-fixed, paraffin-embedded tissues,” Journal of Molecular Diagnostics, vol. 10, no. 3, pp. 203–211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Li, P. Smyth, R. Flavin et al., “Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells,” BMC Biotechnology, vol. 7, article 36, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. W. Tong, P. Fulgham, C. Jay et al., “MicroRNA profile analysis of human prostate cancers,” Cancer Gene Therapy, vol. 16, no. 3, pp. 206–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. L. Sarver, A. J. French, P. M. Borralho et al., “Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states,” BMC Cancer, vol. 9, article 401, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Schaap-Oziemlak, R. A. Raymakers, S. M. Bergevoet et al., “MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human Unrestricted Somatic Stem Cells (USSCs),” Stem Cells and Development, vol. 19, no. 6, pp. 877–885, 2010. View at Publisher · View at Google Scholar
  22. D. Vasilatou, S. Papageorgiou, V. Pappa, E. Papageorgiou, and J. Dervenoulas, “The role of microRNAs in normal and malignant hematopoiesis,” European Journal of Haematology, vol. 84, no. 1, pp. 1–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Wu, H. Jin, Z. Yang et al., “MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2,” Biochemical and Biophysical Research Communications, vol. 392, no. 3, pp. 340–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Zhou, X. Qi, J. A. Potashkin, F. W. Abdul-Karim, and G. I. Gorodeski, “MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript,” Journal of Biological Chemistry, vol. 283, no. 42, pp. 28274–28286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. W. Grol, N. Panupinthu, J. Korcok, S. M. Sims, and S. J. Dixon, “Expression, signaling, and function of P2X7 receptors in bone,” Purinergic Signalling, vol. 5, no. 2, pp. 205–221, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. H. Schulte, T. Marschall, M. Martin et al., “Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma,” Nucleic Acids Research, vol. 38, no. 17, pp. 5919–5928, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Schulte, B. Schowe, P. Mestdagh et al., “Accurate prediction of neuroblastoma outcome based on miRNA expression profiles,” International Journal of Cancer, vol. 127, no. 10, pp. 2374–2385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Fasanaro, S. Greco, M. Lorenzi et al., “An integrated approach for experimental target identification of hypoxia-induced miR-210,” Journal of Biological Chemistry, vol. 284, no. 50, pp. 35134–35143, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Mizuno, Y. Tokuzawa, Y. Ninomiya et al., “MiR-210 promotes osteoblastic differentiation through inhibition of AcvR1b,” FEBS Letters, vol. 583, no. 13, pp. 2263–2268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Maire, J. W. Martin, M. Yoshimoto, S. Chilton-MacNeill, M. Zielenska, and J. A. Squire, “Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma,” Cancer Genet, vol. 204, no. 3, pp. 138–146, 2011. View at Google Scholar